H

HLB Life Science Co Ltd
KOSDAQ:067630

Watchlist Manager
HLB Life Science Co Ltd
KOSDAQ:067630
Watchlist
Price: 10 650 KRW 0.28% Market Closed
Market Cap: 1.3T KRW
Have any thoughts about
HLB Life Science Co Ltd?
Write Note

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
HLB Life Science Co Ltd

Revenue
97.1B KRW
Cost of Revenue
-99.9B KRW
Gross Profit
-2.8B KRW
Operating Expenses
-23.8B KRW
Operating Income
-26.6B KRW
Other Expenses
97.7B KRW
Net Income
71B KRW

Margins Comparison
HLB Life Science Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
KR
HLB Life Science Co Ltd
KOSDAQ:067630
1.3T KRW
-3%
-27%
73%
US
Mckesson Corp
NYSE:MCK
74.9B USD
4%
1%
1%
US
Cencora Inc
NYSE:COR
46.5B USD
3%
1%
1%
US
Amerisourcebergen Corp
LSE:0HF3
46.2B USD
3%
1%
1%
US
Cardinal Health Inc
NYSE:CAH
29.5B USD
3%
1%
1%
US
Henry Schein Inc
NASDAQ:HSIC
8.8B USD
32%
5%
3%
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
30%
9%
7%
CN
Sinopharm Group Co Ltd
HKEX:1099
62.4B HKD
8%
4%
1%
CN
Huadong Medicine Co Ltd
SZSE:000963
57.1B CNY
32%
10%
8%
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
56.7B CNY
11%
3%
1%
IT
Amplifon SpA
MIL:AMP
5.7B EUR
24%
12%
7%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
HLB Life Science Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
KR
HLB Life Science Co Ltd
KOSDAQ:067630
1.3T KRW
22%
14%
-6%
-6%
US
Mckesson Corp
NYSE:MCK
74.9B USD
-105%
4%
27%
18%
US
Cencora Inc
NYSE:COR
46.5B USD
258%
2%
23%
17%
US
Amerisourcebergen Corp
LSE:0HF3
46.2B USD
258%
2%
23%
17%
US
Cardinal Health Inc
NYSE:CAH
29.5B USD
-37%
3%
26%
17%
US
Henry Schein Inc
NASDAQ:HSIC
8.8B USD
9%
3%
8%
5%
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
7%
3%
9%
5%
CN
Sinopharm Group Co Ltd
HKEX:1099
62.4B HKD
12%
2%
15%
7%
CN
Huadong Medicine Co Ltd
SZSE:000963
57.1B CNY
15%
9%
18%
14%
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
56.7B CNY
6%
2%
9%
5%
IT
Amplifon SpA
MIL:AMP
5.7B EUR
14%
4%
11%
6%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.